STERIS (STE) Stock Forecast & Price Target

Q: What analysts cover STERIS?

STERIS has been rated by research analysts at KeyCorp , Piper Sandler , and Weiss Ratings in the past 90 days.

$215.59 +4.99 (+2.37%)

Closing price 06/26/2026 03:59 PM Eastern

Extended Trading

$212.50 -3.09 (-1.44%)

As of 06/26/2026 05:36 PM Eastern

Compare

STERIS - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 4 Analyst Ratings

Sell
0

Hold
1

Buy
3

Based on 4 Wall Street analysts who have issued ratings for STERIS in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for STE.

Consensus Price Target

$278.00
28.95% Upside

According to the 4 analysts' twelve-month price targets for STERIS, the average price target is $278.00. The highest price target for STE is $295.00, while the lowest price target for STE is $269.00. The average price target represents a forecasted upside of 28.95% from the current price of $215.59.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for STE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for STERIS and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STE Analyst Ratings Over Time

Type	Current Forecast 6/27/25 to 6/27/26	1 Month Ago 5/28/25 to 5/28/26	3 Months Ago 3/29/25 to 3/29/26	1 Year Ago 6/27/24 to 6/27/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	6 Buy rating(s)	5 Buy rating(s)
Hold	1 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$278.00	$274.25	$275.20	$263.83
Forecasted Upside	28.95% Upside	27.24% Upside	25.15% Upside	10.56% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

STE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

STE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

STERIS Stock vs. The Competition

Type	STERIS	Medical Companies	Broader Market
Consensus Rating Score	2.75	2.29	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	28.95% Upside	723.87% Upside	14.33% Upside
News Sentiment Rating	Positive News See Recent STE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/27/2026	Weiss Ratings 5 of 5 stars		Downgrade	Hold (C+) ➝ Hold (C)
5/21/2026	Piper Sandler 2 of 5 stars		Reiterated Rating	Overweight	$270.00	+24.54%
5/13/2026	KeyCorp 2 of 5 stars	Brett Fishbin 2 of 5 stars	Lower Target	Overweight	$291.00 ➝ $269.00	+27.55%
8/8/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$276.00 ➝ $295.00	+22.18%
5/29/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Hold	$263.00	+7.33%
5/16/2025	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
5/16/2025	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Turkaly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Market Outperform	$265.00 ➝ $280.00	+11.84%
5/15/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Etoch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$250.00 ➝ $250.00	+1.92%
4/7/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Matson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:40 AM ET.

Should I Buy STERIS Stock? STE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, June 24, 2026. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com.

STERIS
Bull Case

Here are some ways that investors could benefit from investing in STERIS plc:

STERIS plc has demonstrated strong financial performance, with a recent quarterly revenue increase of 6.7% year-over-year, indicating robust demand for its medical equipment and services.
The company has a solid current ratio of 2.09, suggesting it has more than enough short-term assets to cover its liabilities, which is a positive indicator of financial health.
With a recent stock price around $212, STERIS plc is positioned within a reasonable range compared to its 1-year high of $269.44, potentially offering a good entry point for investors.
The company has a consistent dividend payout, recently declaring a quarterly dividend of $0.63 per share, which translates to an annualized yield of 1.2%, appealing to income-focused investors.
STERIS plc has set a positive earnings guidance for FY 2027, projecting earnings per share between 11.100 and 11.300, which could indicate future growth and profitability.

STERIS
Bear Case

Investors should be bearish about investing in STERIS plc for these reasons:

The company recently reported earnings per share of $2.83, which fell short of analysts' expectations by $0.03, raising concerns about its ability to meet future earnings targets.
Insider selling activity has been noted, with key executives selling shares, which could signal a lack of confidence in the company's short-term performance.
Despite a strong revenue performance, the net margin of 13.18% may indicate that the company faces challenges in maintaining profitability amidst rising costs in the medical equipment sector.
The stock has a beta of 0.93, suggesting it is less volatile than the market, which may limit potential high returns for aggressive investors looking for growth.
Analysts have recently adjusted target prices downward, indicating a cautious outlook on the stock's future performance, which could deter potential investors.

STE Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for STERIS is $278.00, with a high forecast of $295.00 and a low forecast of $269.00.

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" STE shares.

According to analysts, STERIS's stock has a predicted upside of 28.95% based on their 12-month stock forecasts.

Over the previous 90 days, STERIS's stock had 2 downgrades by analysts.

STERIS has been rated by research analysts at KeyCorp, Piper Sandler, and Weiss Ratings in the past 90 days.

Analysts like STERIS more than other "medical" companies. The consensus rating for STERIS is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how STE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With STERIS Recommendations

This page (NYSE:STE) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Stock Forecast & Price Target